Application no. and date | 11178912.9 (espacenet) (Federated) (European Patent Register), 20060824 | Patent/reg. no. and date | DK/EP 2402005, 20201216 | Publication date | 20120104 | Priority no. and date | US 710772 P, 20050824, US 772466 P, 20060210 | EP pub. no. and date |
EP 2402005 20120104 | Effective date | | Applicant/owner | Endo Pharmaceuticals Inc., 100 Endo Boulevard
Chadds Ford, PA 19317, US | Applicant ref. no. | P25487DKEP | Inventor | SCIASCIA, Thomas, 108 Oliver Road
Belmont, MA 02478, US, BAICHWAL, Anand, 5 Kendall Drive
Wappingers Falls NY 12590, US, DIEHL, Donald, 27 Jeremy Drive
New Fairfield, CT 06812, US, VOGLER, Brian, PO Box 707
Wingdale NY12594, US | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | Opponent | | IPC Class | A61K 31/485 (2006.01) , A61K 9/22 (2006.01) , A61K 9/24 (2006.01) , A61P 25/04 (2006.01) | Title | Formuleringer med langvarig frigivelse af nalbuphin | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|